- 主题
- 376
- 您的身份
- 病友
- 就诊医院
- 北京协和
- 病理报告
- 滤泡性淋巴瘤1-2级
- 目前状态
- 康复10-20年
参加活动:0 次 组织活动:0 次
您的身份病友
病理报告滤泡性淋巴瘤1-2级
就诊医院北京协和
目前状态康复10-20年
最后登录2024-11-15
|
楼主 |
发表于 2017-8-29 10:32:41
|
显示全部楼层
来自: 中国北京
本帖最后由 橙色雨丝 于 2017-8-29 10:34 编辑
Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study.
补充和替代医疗对终末期癌症患者的生存期及健康相关生存质量的影响:一项前瞻性的分组研究
Yun YH1, Lee MK, Park SM, Kim YA, Lee WJ, Lee KS, Choi JS, Jung KH, Do YR, Kim SY, Heo DS, Kim HT, Park SR.
Author information
Cancer Research Institute, Seoul National University Hospital and College of Medicine, Seoul, Korea. awyun@snu.ac.kr
Abstract
BACKGROUND:
We evaluated whether complementary and alternative medicine (CAM) use influenced outcomes [survival and health-related quality of life (HRQOL)] of cancer patients whose condition had just been judged terminal.
我们对补充和替代医疗是否影响了刚刚被确定为癌症终末期患者的结局(生存期和健康相关的生存质量)进行了分析。
PATIENTS AND METHODS:
From July 2005 to October 2006, we conducted a prospective cohort study of 481 terminally ill cancer patients at 11 university hospitals and the National Cancer Center in Korea. We assessed how the use of CAM affected HRQOL and survival.
从2005年7月到2006年10月,我们对韩国11所大学医院和国家癌症中心的481位癌症终末期患者进行了一项前瞻性的分组研究。我们分析了补充和替代医疗如何影响了生存质量和生存期。
RESULTS:
In a follow-up of 481 patients and 163.8 person-years, we identified 466 deceased cases. On multivariate analyses, CAM users did not have better survival compared with nonusers [adjusted hazard ratio (aHR), 0.91; 95% confidence interval (CI) 0.74-1.10]. Among mind-body interventions, prayer showed significantly worse survival (aHR, 1.56; 95% CI, 1.00-2.43). Clinically, CAM users reported significantly worse cognitive functioning (-11.6 versus -1.3; P < 0.05) and fatigue (9.9 versus -1.0; P < 0.05) than nonusers. Compared with nonusers in subgroup analysis, users of alternative medical treatments, prayer, vitamin supplements, mushrooms, or rice and cereal reported clinically significant worse changes in some HRQOL subscales.
通过对481位患者共163.8个人-年的跟踪随访,我们确认了466个死亡的案例。根据多变量分析,使用补充和替代医疗的患者与不使用的患者相比在生存期上没有优势。在身心干预方面,祈祷显示出明显更差的生存期。临床上,补充和替代医疗的使用者据报告有明显更差的认知能力和疲劳感。经与不使用补充和替代医疗的患者亚组进行比较,使用替代药物治疗,祈祷,维他命补充,蘑菇,大米和谷物的患者在临床上就某些生存质量指标而言明显更差。
CONCLUSION:
While CAM did not provide any definite survival benefit, CAM users reported clinically significant worse HRQOLs.
一方面补充和替代医疗未能提供明确的生存期优势,另一方面使用补充和替代医疗的患者临床生存质量明显更差。
|
|